🎉 Up to 70% Off Selected ItemsShop Sale
Ulcavis® 120 mg Tablets – 56 Tablets
HomeStore

Ulcavis® 120 mg Tablets – 56 Tablets

Ulcavis® 120 mg Tablets – 56 Tablets

It is a bismuth-based gastroprotective medication containing bismuth tripotassium dicitrate. It is commonly used to support the treatment of stomach and duodenal ulcers, gastritis, gastroduodenitis, and conditions associated with Helicobacter pylori. The medication forms a protective barrier on the gastric mucosa and exhibits antibacterial activity against H. pylori. Manufactured by KRKA.

Benefits & Uses

  • Supports treatment of gastric and duodenal ulcers
  • Helps protect and restore the stomach lining
  • Used in Helicobacter pylori eradication regimens in combination with other therapies
  • May help relieve symptoms of chronic gastritis and gastroduodenitis
  • Can be used for functional dyspepsia and certain cases of irritable bowel syndrome with predominant diarrhea.

Active Ingredient

Each film-coated tablet contains:

  • Bismuth Tripotassium Dicitrate – 303.03 mg
    (equivalent to 120 mg bismuth oxide)

Inactive ingredients include:

  • Corn starch
  • Povidone K-30
  • Potassium polyacrylate
  • Macrogol 6000
  • Magnesium stearate
  • Film coating components.

Directions

Use only as directed by a healthcare professional.

Typical adult regimen:

  • 1 tablet 4 times daily (30 minutes before meals and at bedtime), or
  • 2 tablets twice daily.

Treatment duration usually ranges from 4 to 8 weeks depending on the condition being treated. Avoid eating, drinking, or taking antacids within 30 minutes before or after administration.

Warnings

  • For oral use only.
  • Do not use if allergic to bismuth compounds.
  • Not recommended during pregnancy or breastfeeding.
  • Use with caution in patients with severe kidney impairment.
  • Temporary darkening of stools or tongue may occur.
  • Do not exceed recommended treatment duration without medical supervision.
  • Keep out of reach of children.

Form & Size

Film-coated tablets
Strength: 120 mg
Package size: 56 tablets

Storage

Store at temperatures below 25°C (77°F) in the original packaging, protected from moisture and out of reach of children.

General Disclaimer

This product should be used according to professional medical guidance. Consult your healthcare provider if symptoms persist, worsen, or if you suspect Helicobacter pylori infection.

$14.00

Original: $39.99

-65%
Ulcavis® 120 mg Tablets – 56 Tablets

$39.99

$14.00

Ulcavis® 120 mg Tablets – 56 Tablets

It is a bismuth-based gastroprotective medication containing bismuth tripotassium dicitrate. It is commonly used to support the treatment of stomach and duodenal ulcers, gastritis, gastroduodenitis, and conditions associated with Helicobacter pylori. The medication forms a protective barrier on the gastric mucosa and exhibits antibacterial activity against H. pylori. Manufactured by KRKA.

Benefits & Uses

  • Supports treatment of gastric and duodenal ulcers
  • Helps protect and restore the stomach lining
  • Used in Helicobacter pylori eradication regimens in combination with other therapies
  • May help relieve symptoms of chronic gastritis and gastroduodenitis
  • Can be used for functional dyspepsia and certain cases of irritable bowel syndrome with predominant diarrhea.

Active Ingredient

Each film-coated tablet contains:

  • Bismuth Tripotassium Dicitrate – 303.03 mg
    (equivalent to 120 mg bismuth oxide)

Inactive ingredients include:

  • Corn starch
  • Povidone K-30
  • Potassium polyacrylate
  • Macrogol 6000
  • Magnesium stearate
  • Film coating components.

Directions

Use only as directed by a healthcare professional.

Typical adult regimen:

  • 1 tablet 4 times daily (30 minutes before meals and at bedtime), or
  • 2 tablets twice daily.

Treatment duration usually ranges from 4 to 8 weeks depending on the condition being treated. Avoid eating, drinking, or taking antacids within 30 minutes before or after administration.

Warnings

  • For oral use only.
  • Do not use if allergic to bismuth compounds.
  • Not recommended during pregnancy or breastfeeding.
  • Use with caution in patients with severe kidney impairment.
  • Temporary darkening of stools or tongue may occur.
  • Do not exceed recommended treatment duration without medical supervision.
  • Keep out of reach of children.

Form & Size

Film-coated tablets
Strength: 120 mg
Package size: 56 tablets

Storage

Store at temperatures below 25°C (77°F) in the original packaging, protected from moisture and out of reach of children.

General Disclaimer

This product should be used according to professional medical guidance. Consult your healthcare provider if symptoms persist, worsen, or if you suspect Helicobacter pylori infection.

Product Information

Shipping & Returns

Description

It is a bismuth-based gastroprotective medication containing bismuth tripotassium dicitrate. It is commonly used to support the treatment of stomach and duodenal ulcers, gastritis, gastroduodenitis, and conditions associated with Helicobacter pylori. The medication forms a protective barrier on the gastric mucosa and exhibits antibacterial activity against H. pylori. Manufactured by KRKA.

Benefits & Uses

  • Supports treatment of gastric and duodenal ulcers
  • Helps protect and restore the stomach lining
  • Used in Helicobacter pylori eradication regimens in combination with other therapies
  • May help relieve symptoms of chronic gastritis and gastroduodenitis
  • Can be used for functional dyspepsia and certain cases of irritable bowel syndrome with predominant diarrhea.

Active Ingredient

Each film-coated tablet contains:

  • Bismuth Tripotassium Dicitrate – 303.03 mg
    (equivalent to 120 mg bismuth oxide)

Inactive ingredients include:

  • Corn starch
  • Povidone K-30
  • Potassium polyacrylate
  • Macrogol 6000
  • Magnesium stearate
  • Film coating components.

Directions

Use only as directed by a healthcare professional.

Typical adult regimen:

  • 1 tablet 4 times daily (30 minutes before meals and at bedtime), or
  • 2 tablets twice daily.

Treatment duration usually ranges from 4 to 8 weeks depending on the condition being treated. Avoid eating, drinking, or taking antacids within 30 minutes before or after administration.

Warnings

  • For oral use only.
  • Do not use if allergic to bismuth compounds.
  • Not recommended during pregnancy or breastfeeding.
  • Use with caution in patients with severe kidney impairment.
  • Temporary darkening of stools or tongue may occur.
  • Do not exceed recommended treatment duration without medical supervision.
  • Keep out of reach of children.

Form & Size

Film-coated tablets
Strength: 120 mg
Package size: 56 tablets

Storage

Store at temperatures below 25°C (77°F) in the original packaging, protected from moisture and out of reach of children.

General Disclaimer

This product should be used according to professional medical guidance. Consult your healthcare provider if symptoms persist, worsen, or if you suspect Helicobacter pylori infection.

Ulcavis® 120 mg Tablets – 56 Tablets | Lotus Pharmacy & Kids Boutique